INTRODUCTION
In western populations, the prevalence of deep vein thrombosis (DVT) after total knee arthroplasty (TKA) has been reported to be 46 to 84%. [1] [2] [3] [4] In Asian populations it is lower [5] [6] [7] but recently has been increasing. [8] [9] [10] This difference may be due to a lack of prothrombotic clotting factor polymorphisms (factor V Leiden and prothrombin G20210A) among Asians. 11, 12 Development of DVT is multifactorial and therefore different physical and pharmacological modalities have been used for thromboembolic prophylaxis, 13 but there is no consensus on the optimal strategy. We conducted a randomised controlled trial to compare the efficacy and safety of different modes of thromboembolic prophylaxis for elective TKA in Asian patients.
MATERIALS AND METHODS
From January 2003 to May 2004, 440 patients who underwent elective TKA were prospectively studied. Low-risk patients and those who did not have any predisposition to thromboembolism were included. Informed consent was obtained from each patient and the study was approved by our ethics board.
Exclusion criteria were the use of anticoagulants or aspirin, a history of pulmonary embolism (PE) or DVT in the previous year, obesity (body mass index of >30 kg/m 2 ), preoperative prolonged immobilisation or being wheelchair bound, bleeding tendency or a history of gastro-intestinal bleeding, surgery in the previous 6 months, cerebrovascular accident in the previous 3 months, uncontrolled hypertension, congestive cardiac failure, renal or liver impairment, allergy to heparin or heparin-induced thrombocytopenia, varicose veins or chronic venous insufficiency, peripheral vascular disease, skin ulcers, dermatitis or wounds, and malignancy.
Postoperatively, patients were randomised into 4 equal groups. Group 1 received no prophylaxis and served as controls. Group 2 received graduated compression stockings (GCS) applied directly to both legs. Group 3 was treated with intermittent pneumatic compression (IPC), with each inflationdeflation cycle lasting one minute and pressures up to 45 to 52 mm Hg. Group 4 received subcutaneous injections of enoxaparin sodium 40 mg once daily. Prophylaxis was continued until day 5 to 7 or stopped earlier if patients were suspected to have DVT or PE based on bilateral duplex ultrasonography (carried out by one of 3 dedicated ultrasonographers blinded to the prophylactic method used). Rehabilitation protocols were standardised, with continuous passive movements initiated on day 2 and ambulation on day 3.
The primary endpoint was detection of DVT; the diagnostic criteria were loss of compressibility of a vein or visualisation of thrombosis. Patients suspected of PE underwent ventilation-perfusion scanning and spiral computed tomography of the chest. Patients with any proximal DVT received anti-coagulation therapy supervised by a haematologist. Patients with nonsymptomatic distal DVTs were not treated, but monitored with duplex ultrasonography at 2-week intervals.
The secondary endpoint was the development of bleeding complications. Haemarthrosis necessitating aspiration or arthrotomy for drainage was categorised as a major complication. Severe bruising around a wound (extending to the popliteal region, midcalf or mid-thigh) and haemarthrosis not requiring intervention were categorised as minor complications.
Postoperative blood loss via a drain, drop in haemoglobin level, and receipt of transfusions in each patient group were compared. At one-month follow-up, patients were examined for any symptoms suggestive of DVT or post-phlebitis syndrome.
Patients re-admitted within one month were assessed for any late DVT or DVT-related complications. The rates of DVT and PE in the 4 groups were compared using the Chi squared test. Blood loss, units of transfusion, operating time, tourniquet application time, and decrease in haemoglobin level were compared using the Kruskal-Wallis test. Differences were considered significant when the p value was <0.05.
RESULTS
There were no significant inter-group differences in patient characteristics (Table 1 ). In the control, GCS, IPC, and enoxaparin groups respectively, 24, 14, 9, and 6 patients developed DVT (p=0.001, Table 2 ). Among them, 3, 1, 0, and 1 were proximal DVTs (p=0.279) and 21, 13, 9 and 5 were distal DVTs (p=0.003). One patient each in the control and GCS groups developed symptomatic PE and were treated successfully. On comparing the controls and patients in each treatment group, DVT prevalence was significantly lower in the IPC (p=0.032) and enoxaparin (p=0.001) groups (Table  3) . Risk factors for DVT as opposed to not developing DVT in the controls were significantly longer tourniquet application (94 vs 84 minutes, p=0.029) and operating time (97 vs 86 minutes, p=0.016) [ Table 4 ].
Two patients in the enoxaparin group developed major bleeding necessitating intervention. The number of patients with bleeding complications was not significantly different between groups (p=0.304, Table 1 ).
The enoxaparin group endured the highest blood loss from the drain and decrease in haemoglobin level, but not significantly different from the other groups (p=0.115, Table 1 ). The proportion of patients who received transfusions was not significantly different between groups (p=0.1), but the transfusion volume per patient in the enoxaparin group was 3 times that in the controls (0.1 vs 0.34 unit, p=0.029, Table 1 ). There was no adverse effect such as skin rash, swelling above the appliance, pressure necrosis of the skin or peroneal nerve palsy related to the use of GCS and IPC.
At the one-month follow-up, no patient developed symptomatic late DVT or post-phlebitis syndrome. One patient each in the control and GCS groups had non-specific aches in the leg. Five patients (2 each in the control and GCS groups and one in the IPC group) were re-admitted due to superficial wound infections.
Chemoprophylaxis alone or in combination with mechanical methods are more commonly used in the west, because of the higher risk of DVT. [1] [2] [3] [4] 26 The risk is lower in Asian patients and chemoprophylaxis is usually not undertaken, but recent studies have stressed the use of routine prophylaxis because of increasing risk in Asians. [5] [6] [7] Studies from South Korea 27 and Taiwan 28 using venography have reported the overall DVT rates of 41% and 64%, respectively, which were higher than the 22% rate noted in our study based on duplex ultrasonography. We preferred using duplex 
Table 2 Prevalence of deep vein thrombosis (DVT) or symptomatic pulmonary embolism (PE) in the 4 groups
One patient in the GCS group was re-admitted due to a cerebrovascular accident leading to brain infarction, but with no DVT in both legs. One patient in the IPC group was re-admitted due to an unrelated cause (multiple injuries after a fall).
DISCUSSION
Studies comparing different thromboembolic prophylaxis modalities have been reported in western 4, [14] [15] [16] [17] [18] [19] [20] [21] [22] and Asian patients [23] [24] [25] Despite little scientific evidence, factors such as age, sex, weight, ethnicity, and smoking have all been regarded as associated with thromboembolism, as were peri-operative parameters (haematocrit level, type of anaesthesia, use of tourniquet, intra-or extramedullary techniques, duration of operation, and blood transfusions). Earlier studies failed to identify any risk factors of thromboembolism. 5, 33 In our study, prolonged tourniquet application and operating time were risk factors, for which prophylaxis appeared appropriate after TKA.
In 2 meta-analyses on efficacy of various thromboprophylactic modes, IPC and low-molecularweight heparin (LMWH) were significantly better than aspirin or warfarin. 4, 18 Fixed-dose enoxaparin was significantly more effective than adjusted-dose warfarin in reducing the occurrence of asymptomatic venous thromboembolism. 16, 22 Moreover, LMWH in combination with IPC was significantly better than LMWH with GCS in DVT prophylaxis after hip or knee arthroplasty. 14 The major risk associated with pharmacological prophylaxis was bleeding. The use of enoxaparin resulted in significantly more bleeding complications (11%). 19 In a case-control study, 3.3% of enoxaparin recipients had major bleeding complications, and the associated decrease in haemoglobin level and receipt of transfusions were greater, but not significantly. 20 Although enoxaparin was the most effective in 
Table 3 Comparison of the point prevalence of deep vein thrombosis (DVT) in the control group with each prophylaxis group
preventing DVT after TKA, major bleeding made it less desirable. IPC is therefore recommended for routine prophylaxis for TKA in Asian patients.
